Logo image of B7E.DE

BLUE CAP AG (B7E.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:B7E - DE000A0JM2M1 - Common Stock

18.4 EUR
-0.1 (-0.54%)
Last: 1/14/2026, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to B7E. B7E was compared to 125 industry peers in the Capital Markets industry. B7E scores excellent on profitability, but there are some minor concerns on its financial health. B7E is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • B7E had positive earnings in the past year.
  • B7E had a positive operating cash flow in the past year.
  • B7E had positive earnings in 4 of the past 5 years.
  • B7E had a positive operating cash flow in each of the past 5 years.
B7E.DE Yearly Net Income VS EBIT VS OCF VS FCFB7E.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • With an excellent Return On Assets value of 9.48%, B7E belongs to the best of the industry, outperforming 87.20% of the companies in the same industry.
  • B7E has a better Return On Equity (20.25%) than 81.60% of its industry peers.
  • B7E's Return On Invested Capital of 6.33% is fine compared to the rest of the industry. B7E outperforms 74.40% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for B7E is below the industry average of 8.63%.
  • The 3 year average ROIC (5.02%) for B7E is below the current ROIC(6.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROIC 6.33%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
B7E.DE Yearly ROA, ROE, ROICB7E.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • B7E has a Profit Margin of 11.71%. This is comparable to the rest of the industry: B7E outperforms 48.00% of its industry peers.
  • B7E's Profit Margin has improved in the last couple of years.
  • B7E has a Operating Margin of 8.02%. This is comparable to the rest of the industry: B7E outperforms 53.60% of its industry peers.
  • In the last couple of years the Operating Margin of B7E has grown nicely.
  • With a decent Gross Margin value of 49.70%, B7E is doing good in the industry, outperforming 63.20% of the companies in the same industry.
  • In the last couple of years the Gross Margin of B7E has grown nicely.
Industry RankSector Rank
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
B7E.DE Yearly Profit, Operating, Gross MarginsB7E.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, B7E has about the same amount of shares outstanding.
  • B7E has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for B7E has been reduced compared to a year ago.
B7E.DE Yearly Shares OutstandingB7E.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
B7E.DE Yearly Total Debt VS Total AssetsB7E.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • B7E has an Altman-Z score of 2.20. This is not the best score and indicates that B7E is in the grey zone with still only limited risk for bankruptcy at the moment.
  • B7E has a Altman-Z score of 2.20. This is in the better half of the industry: B7E outperforms 71.20% of its industry peers.
  • B7E has a debt to FCF ratio of 4.61. This is a neutral value as B7E would need 4.61 years to pay back of all of its debts.
  • B7E's Debt to FCF ratio of 4.61 is fine compared to the rest of the industry. B7E outperforms 72.80% of its industry peers.
  • B7E has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • B7E's Debt to Equity ratio of 0.32 is fine compared to the rest of the industry. B7E outperforms 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Altman-Z 2.2
ROIC/WACCN/A
WACCN/A
B7E.DE Yearly LT Debt VS Equity VS FCFB7E.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • B7E has a Current Ratio of 1.73. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.73, B7E is doing good in the industry, outperforming 76.80% of the companies in the same industry.
  • B7E has a Quick Ratio of 1.39. This is a normal value and indicates that B7E is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.39, B7E is doing good in the industry, outperforming 75.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.39
B7E.DE Yearly Current Assets VS Current LiabilitesB7E.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 292.72% over the past year.
  • The Earnings Per Share has been growing by 33.00% on average over the past years. This is a very strong growth
  • B7E shows a decrease in Revenue. In the last year, the revenue decreased by -0.59%.
  • The Revenue has been decreasing by -1.79% on average over the past years.
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%

3.2 Future

  • B7E is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -60.16% yearly.
  • Based on estimates for the next years, B7E will show a decrease in Revenue. The Revenue will decrease by -5.74% on average per year.
EPS Next Y-37.05%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
EPS Next 5YN/A
Revenue Next Year-38.12%
Revenue Next 2Y-19.99%
Revenue Next 3Y-12.19%
Revenue Next 5Y-5.74%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
B7E.DE Yearly Revenue VS EstimatesB7E.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
B7E.DE Yearly EPS VS EstimatesB7E.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.08, the valuation of B7E can be described as very cheap.
  • 97.60% of the companies in the same industry are more expensive than B7E, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.33, B7E is valued rather cheaply.
  • B7E is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 4.08
Fwd PE N/A
B7E.DE Price Earnings VS Forward Price EarningsB7E.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, B7E is valued cheaply inside the industry as 95.20% of the companies are valued more expensively.
  • 92.00% of the companies in the same industry are more expensive than B7E, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.94
EV/EBITDA 3.1
B7E.DE Per share dataB7E.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • B7E has a very decent profitability rating, which may justify a higher PE ratio.
  • B7E's earnings are expected to decrease with -60.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%

4

5. Dividend

5.1 Amount

  • B7E has a Yearly Dividend Yield of 3.85%.
  • B7E's Dividend Yield is a higher than the industry average which is at 3.32.
  • B7E's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 3.85%

5.2 History

  • The dividend of B7E decreases each year by -2.84%.
Dividend Growth(5Y)-2.84%
Div Incr Years0
Div Non Decr Years1
B7E.DE Yearly Dividends per shareB7E.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • The Dividend Rate of B7E has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
B7E.DE Yearly Income VS Free CF VS DividendB7E.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

BLUE CAP AG

FRA:B7E (1/14/2026, 7:00:00 PM)

18.4

-0.1 (-0.54%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-04
Earnings (Next)03-26
Inst Owners25.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap82.62M
Revenue(TTM)174.60M
Net Income(TTM)20.44M
Analysts82.86
Price Target30.87 (67.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.85%
Yearly Dividend0.65
Dividend Growth(5Y)-2.84%
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)283.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 4.08
Fwd PE N/A
P/S 0.47
P/FCF 5.94
P/OCF 4.08
P/B 0.82
P/tB 1.56
EV/EBITDA 3.1
EPS(TTM)4.51
EY24.51%
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)3.1
FCFY16.84%
OCF(TTM)4.51
OCFY24.54%
SpS38.89
BVpS22.48
TBVpS11.77
PEG (NY)N/A
PEG (5Y)0.12
Graham Number47.76
Profitability
Industry RankSector Rank
ROA 9.48%
ROE 20.25%
ROCE 9.09%
ROIC 6.33%
ROICexc 9.23%
ROICexgc 16.8%
OM 8.02%
PM (TTM) 11.71%
GM 49.7%
FCFM 7.97%
ROA(3y)0.97%
ROA(5y)2.64%
ROE(3y)1.48%
ROE(5y)6.13%
ROIC(3y)5.02%
ROIC(5y)5.41%
ROICexc(3y)6.63%
ROICexc(5y)7.25%
ROICexgc(3y)11.85%
ROICexgc(5y)10.59%
ROCE(3y)7.26%
ROCE(5y)7.8%
ROICexgc growth 3Y54.39%
ROICexgc growth 5Y35.47%
ROICexc growth 3Y30.62%
ROICexc growth 5Y18.26%
OM growth 3Y20.55%
OM growth 5Y16.85%
PM growth 3Y49.43%
PM growth 5Y38.76%
GM growth 3Y2.24%
GM growth 5Y2.56%
F-Score8
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.61
Debt/EBITDA 1.04
Cap/Depr 37.43%
Cap/Sales 3.64%
Interest Coverage 3.69
Cash Conversion 65.44%
Profit Quality 68.08%
Current Ratio 1.73
Quick Ratio 1.39
Altman-Z 2.2
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)25.83%
Cap/Depr(5y)33.96%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)292.72%
EPS 3Y33.45%
EPS 5Y33%
EPS Q2Q%1599.7%
EPS Next Y-37.05%
EPS Next 2Y-41.74%
EPS Next 3Y-60.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y-8.3%
Revenue growth 5Y-1.79%
Sales Q2Q%-4.28%
Revenue Next Year-38.12%
Revenue Next 2Y-19.99%
Revenue Next 3Y-12.19%
Revenue Next 5Y-5.74%
EBIT growth 1Y224.21%
EBIT growth 3Y10.55%
EBIT growth 5Y14.76%
EBIT Next Year-0.64%
EBIT Next 3Y-20.6%
EBIT Next 5Y-13.53%
FCF growth 1Y-38.99%
FCF growth 3Y7.4%
FCF growth 5YN/A
OCF growth 1Y-27.35%
OCF growth 3Y1.47%
OCF growth 5Y47.8%

BLUE CAP AG / B7E.DE FAQ

What is the ChartMill fundamental rating of BLUE CAP AG (B7E.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to B7E.DE.


Can you provide the valuation status for BLUE CAP AG?

ChartMill assigns a valuation rating of 5 / 10 to BLUE CAP AG (B7E.DE). This can be considered as Fairly Valued.


What is the profitability of B7E stock?

BLUE CAP AG (B7E.DE) has a profitability rating of 7 / 10.


What is the earnings growth outlook for BLUE CAP AG?

The Earnings per Share (EPS) of BLUE CAP AG (B7E.DE) is expected to decline by -37.05% in the next year.


Is the dividend of BLUE CAP AG sustainable?

The dividend rating of BLUE CAP AG (B7E.DE) is 4 / 10 and the dividend payout ratio is 0%.